Annual Retained Earnings
-$285.93 M
-$71.17 M-33.14%
31 December 2023
Summary:
Inozyme Pharma annual retained earnings is currently -$285.93 million, with the most recent change of -$71.17 million (-33.14%) on 31 December 2023. During the last 3 years, it has fallen by -$194.85 million (-213.95%). INZY annual retained earnings is now -1815.39% below its all-time high of -$14.93 million, reached on 31 December 2018.INZY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$360.88 M
-$24.57 M-7.31%
30 September 2024
Summary:
Inozyme Pharma quarterly retained earnings is currently -$360.88 million, with the most recent change of -$24.57 million (-7.31%) on 30 September 2024. Over the past year, it has dropped by -$96.49 million (-36.50%). INZY quarterly retained earnings is now -941.44% below its all-time high of -$34.65 million, reached on 31 December 2019.INZY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.1% | -36.5% |
| 3 y3 years | -213.9% | -179.9% |
| 5 y5 years | -1815.4% | - |
INZY Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -213.9% | at low | -179.9% | at low |
| 5 y | 5 years | -1815.4% | at low | -941.4% | at low |
| alltime | all time | -1815.4% | at low | -941.4% | at low |
Inozyme Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$360.88 M(+7.3%) |
| June 2024 | - | -$336.31 M(+8.7%) |
| Mar 2024 | - | -$309.28 M(+8.2%) |
| Dec 2023 | -$285.93 M(+33.1%) | -$285.93 M(+8.1%) |
| Sept 2023 | - | -$264.39 M(+6.7%) |
| June 2023 | - | -$247.75 M(+6.7%) |
| Mar 2023 | - | -$232.16 M(+8.1%) |
| Dec 2022 | -$214.76 M | -$214.76 M(+9.5%) |
| Sept 2022 | - | -$196.22 M(+9.1%) |
| June 2022 | - | -$179.84 M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$164.58 M(+11.4%) |
| Dec 2021 | -$147.70 M(+62.2%) | -$147.70 M(+14.5%) |
| Sept 2021 | - | -$128.95 M(+12.5%) |
| June 2021 | - | -$114.67 M(+12.3%) |
| Mar 2021 | - | -$102.13 M(+12.1%) |
| Dec 2020 | -$91.08 M(+162.8%) | -$91.08 M(+13.9%) |
| Sept 2020 | - | -$79.96 M(+54.2%) |
| June 2020 | - | -$51.86 M(-13.8%) |
| Mar 2020 | - | -$60.15 M(+73.6%) |
| Dec 2019 | -$34.65 M(+132.1%) | -$34.65 M |
| Dec 2018 | -$14.93 M | - |
FAQ
- What is Inozyme Pharma annual retained earnings?
- What is the all time high annual retained earnings for Inozyme Pharma?
- What is Inozyme Pharma annual retained earnings year-on-year change?
- What is Inozyme Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Inozyme Pharma?
- What is Inozyme Pharma quarterly retained earnings year-on-year change?
What is Inozyme Pharma annual retained earnings?
The current annual retained earnings of INZY is -$285.93 M
What is the all time high annual retained earnings for Inozyme Pharma?
Inozyme Pharma all-time high annual retained earnings is -$14.93 M
What is Inozyme Pharma annual retained earnings year-on-year change?
Over the past year, INZY annual retained earnings has changed by -$71.17 M (-33.14%)
What is Inozyme Pharma quarterly retained earnings?
The current quarterly retained earnings of INZY is -$360.88 M
What is the all time high quarterly retained earnings for Inozyme Pharma?
Inozyme Pharma all-time high quarterly retained earnings is -$34.65 M
What is Inozyme Pharma quarterly retained earnings year-on-year change?
Over the past year, INZY quarterly retained earnings has changed by -$96.49 M (-36.50%)